PackTalk is a blog for the Healthcare Packaging Industry

Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test


Published on June 4, 2020

Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19. 

Eli Lilly is anticipating results to their study by end of June. Read more about the treatment here.


Comments (0)

Related Articles

How One Patient’s Experience Became a Profession

September 24, 2023

It was 12 years ago this past summer, but I can remember it all like it was yesterday. I was getting headaches that were a stinging pain in the back of my head. They would come and go, and often with a quick movement the pain would change. I was also...

Learn More

The History of DuPont™ Tyvek®

September 24, 2023

As a material that took 15 years to fully develop and another 15 years to hit the mainstream market, the story of DuPont™ Tyvek® is one of humble beginnings. Fast forward to today, Tyvek® is recognized as a global leader in sterile packaging and shows no...

Learn More

How to Measure and Select the Best Medical Packaging Materials

September 24, 2023

When facing customer inquiries about packaging materials, some of the most common questions we encounter are: What is the thickness of the film material; how do you convert mil and ga; and, how thick is X ga material? When selecting packaging materials,...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.